tiprankstipranks
Challenger Limited (AU:CGF)
ASX:CGF
Australian Market

Challenger (CGF) Earnings Dates, Call Summary & Reports

42 Followers

Earnings Data

Report Date
Aug 17, 2026
TBA (Confirmed)
Period Ending
2026 (Q4)
Consensus EPS Forecast
0.33
Last Year’s EPS
0.31
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Q2 2026
Earnings Call Date:Feb 17, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasized strong operational and strategic progress: record annuity sales and book growth, earnings and ROE above targets, a sizeable after‑tax asset experience, a ratings upgrade, strengthened liquidity and origination activity, plus shareholder returns via a dividend increase and $150m buyback. Headwinds were clearly acknowledged — notably very tight credit spreads compressing reinvestment margins, higher near‑term liquidity holdings, regulatory and licensing timing uncertainty for offshore expansion, and an incomplete Pepper Money discussion — but management framed these as manageable, temporary or strategic trade‑offs while reiterating full‑year guidance and long‑term targets. Overall, positive execution of strategy and capital strength outweigh the cyclical and execution risks discussed.
Company Guidance
Challenger reaffirmed FY26 normalized EPS guidance of $0.66–$0.72 per share (H1 delivered $0.333) and left through‑the‑cycle targets for ROE, cost‑to‑income and capital unchanged; H1 metrics included normalized ROE 11.4% (above the full‑year target of 10.7%, +70bps outperformance), normalized NPAT $229m (+2%), statutory NPAT $339m, Life normalized NPAT $226m (+1%), group net income $487m (+1%) and total expenses $154m (flat) with cost‑to‑income improving ~30bps and sitting below the 32–34% target range; management announced a fully franked interim dividend up 7% to $0.155 per share and a proposed $150m on‑market buyback, reported Life PCA of 1.58x with $1.7bn of capital above APRA minimum (pro‑forma ~1.74x day‑1 of new standards, ~1.82x at long‑term spreads), and highlighted growth metrics—record annuity sales $3.8bn (+32%; domestic $3.1bn,+37%; offshore $0.7bn,+13%), total life sales $5.1bn (+11%), book growth 5.8%, annuity book growth 7.4%, cash & equivalents $3.3bn (up 27%), $105m after‑tax asset experience and $5.9bn of originations (incl. $2.5bn private credit)—while flagging further capital‑framework work ahead of APRA reforms effective 1 July 2026.
Earnings Growth and Profitability
Normalized EPS of $0.333 in H1, up 2%; normalized NPAT $229m, up 2%; statutory NPAT $339m reflecting a positive after-tax asset experience of $105m. Group normalized ROE 11.4%, above full‑year target of 10.7% (outperformance 70 bps).
Record Annuity and Life Sales
Total life sales rose 11% to $5.1bn; record annuity sales of $3.8bn (up 32%). Domestic annuity sales up 37% (domestic figure cited as $3.1bn in CEO remarks); offshore reinsurance annuity sales up 13% to $0.7bn. Annuity book growth 7.4% and overall book growth 5.8%.
Strong Capital Position and Rating Upgrade
Life company PCA ratio 1.58x at 31 Dec with $1.7bn of capital above APRA minimum; S&P upgraded CLC and Challenger Limited one notch (CLC to A+, Challenger Limited to A-). Pro‑forma PCA expected to increase ~16 bps to 1.74 on day 1 under new APRA standards (to ~1.82 if spreads at long‑term average).
Shareholder Returns and Capital Management
Interim fully franked dividend increased 7% to $0.155 per share. Board announced an initial on‑market buyback of $150m as a signal of intent to return capital while preserving flexibility for growth.
Balance Sheet and Liquidity Actions
Average investment assets increased ~5%; cash and equivalents increased 27% to $3.3bn ($700m increase) to support shorter‑duration institutional business and provide deployment flexibility. Invested an additional $1.6bn into high-quality fixed income (cash and AAA securities).
Asset Origination and Distribution Momentum
Originations of $5.9bn during H1 including $2.5bn of private credit. In talks regarding a potential minority stake (up to 25%) in Pepper Money to expand origination capability. Third‑party FUM for Challenger Investment Management up at a 38% four‑year CAGR to $3.1bn; Fidante net flows $1.5bn in H1.
Funds Management and Product Innovation
Funds Management normalized NPAT $29m, up 7% driven by higher net fee income and cost efficiencies. Launched LiFTS income notes platform and acquired an equity stake in Fulcrum Asset Management (recognized $12.6bn FUM addition); alternatives now ~15% of Fidante FUM.
Cost Discipline and Efficiency
Total expenses flat at $154m; cost-to-income ratio improved by ~30 bps and outperformed target range (32–34%), recording the lowest half‑year cost-to-income ratio the company has delivered.
Strategic Positioning and Regulatory Opportunity
Management highlighted participation in APRA capital standard reform as materially positive; strategy to become less capital‑intensive over time and shift asset mix toward fixed income to reduce earnings volatility and improve ROE through the cycle.

Challenger (AU:CGF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AU:CGF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 17, 2026
2026 (Q4)
0.33 / -
0.31
Feb 17, 2026
2026 (Q2)
0.32 / 0.31
0.2937.17% (+0.02)
Aug 18, 2025
2025 (Q4)
0.31 / 0.31
0.2897.27% (+0.02)
Feb 17, 2025
2025 (Q2)
0.30 / 0.29
0.2930.00% (0.00)
Aug 12, 2024
2024 (Q4)
0.29 / 0.29
0.25911.58% (+0.03)
Feb 12, 2024
2024 (Q2)
0.27 / 0.29
0.24519.59% (+0.05)
Aug 14, 2023
2023 (Q4)
0.25 / 0.26
0.19930.15% (+0.06)
Feb 13, 2023
2023 (Q2)
0.23 / 0.24
0.20718.36% (+0.04)
Aug 15, 2022
2022 (Q4)
0.21 / 0.20
0.17811.80% (+0.02)
Feb 16, 2022
2022 (Q2)
0.31 / 0.21
0.1815.00% (+0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

AU:CGF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 17, 2026
AU$8.08AU$8.75+8.27%
Aug 18, 2025
AU$7.97AU$8.17+2.55%
Feb 17, 2025
AU$5.77AU$5.25-8.97%
Aug 12, 2024
AU$6.35AU$6.76+6.54%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Challenger Limited (AU:CGF) report earnings?
Challenger Limited (AU:CGF) is schdueled to report earning on Aug 17, 2026, TBA (Confirmed).
    What is Challenger Limited (AU:CGF) earnings time?
    Challenger Limited (AU:CGF) earnings time is at Aug 17, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Challenger Limited stock?
          The P/E ratio of Challenger is N/A.
            What is AU:CGF EPS forecast?
            AU:CGF EPS forecast for the fiscal quarter 2026 (Q4) is 0.33.